NexImmune
Latest round
- Series A
Last raised
- Jul 2018
Total raised
- Undisclosed
Investors
- 1
About NexImmune
Founded in 2011 and based in Maryland, US, NexImmune, Inc. is a biotechnology company that develops T cell immunotherapies based on its AIM (artificial immune modulation) technology. SVP Mathias Oelke co-founded the company and was managed by CEO Scott Carmer since 2014. NexImmune, Inc. In February 2021, NexImmune, Inc. has listed for an IPO (Initial Public Offering) on the Nasdaq under the ticker symbol NEXI.'s R&D team provides AIM technology that enables the development of ACT (adoptive cellular therapy) products manufactured by AIM nanoparticles designed to mimic natural immune functions antigen-presenting cells and treat cancer, infectious disease, and autoimmune disorders. The company's pipeline includes NEXi-001, NEXI-002, and injectable AIM.
Who invested in NexImmune
1 investor across 1 round
See all investors in NexImmune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 1, 2018
Amount
Undisclosed
Investors
Questions about NexImmune
Who invested in NexImmune?
NexImmune has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NexImmune raised?
NexImmune has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NexImmune last raise money?
NexImmune's most recent round on record is a Series A, in Jul 2018.
What does NexImmune do?
Founded in 2011 and based in Maryland, US, NexImmune, Inc.
Where is NexImmune headquartered?
NexImmune is headquartered in Gaithersburg, US.
Which VCs invest in companies like NexImmune?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NexImmune's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NexImmune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.